USPSTF Statement on Use of Vitamin, Mineral, Multivitamin Supplements to Prevent Cardiovascular Disease, Cancer

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JUNE 21, 2022

Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 301-951-9203. The full report and related articles are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time and all USPSTF articles remain free indefinitely https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.8970?guestAccessKey=2a436fd3-f03d-453b-a0e9-a29595310e8e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062122

 

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease (CVD) or cancer and concludes that the current evidence is insufficient to make a recommendation about the use of multivitamin and single- or paired-nutrient supplements (other than beta carotene and vitamin E) for the prevention of CVD or cancer. According to National Health and Nutrition Examination Survey data, 52% of surveyed adults reported using at least one dietary supplement in the prior 30 days and 31% reported using a multivitamin-mineral supplement. Inflammation and oxidative stress have been shown to have a role in both CVD and cancer, and dietary supplements may have anti-inflammatory and antioxidative effects. This has served as a rationale for proposing dietary supplements as a means to prevent both CVD and cancer. The USPSTF routinely makes recommendations about the effectiveness of preventive care services, and this recommendation replaces and is consistent with its 2014 statement.

 

(doi:10.1001/jama.2022.8970)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.